ATRenew Inc ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $22.6B+32.4% YoYTTM through 31 Dec 2025
Net Income $48.1MTTM through 31 Dec 2025
Free Cash Flow -$79.9MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 21.8% |
| EBITDA Margin | 0.4% |
| Operating Margin | 3.0% |
| Net Margin | 2.2% |
Returns
10.9%ROE
7.2%ROA
12.1%ROIC
Balance Sheet Health
Debt / Equity0.07x
Current Ratio2.42x
Net Debt-$1.4Bnet cash position
Cash & Equivalents$219.9M
Quality Metrics
Altman Z-Score27.08
Piotroski F-Score2 / 9
FCF Margin-0.4%
Earnings-Beat Rate75.0%
Multi-Year Trend
Diluted EPS$0.30TTMFY2025: $2.07
Dividend
$0.10Per share, FY20262.48%Yield
Capital Allocation
R&D Spend$34.9M
Capex Intensity0.3%
Financials converted at 6.9961 from CNY.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.